Molecular Influence of Resiniferatoxin on the Urinary Bladder Wall Based on Differential Gene Expression Profiling

• Published in: Cells (Basel, Switzerland) Switzerland), 2023-01, Vol.12 (3), p.462
• Main Authors: Lepiarczyk, Ewa, Paukszto, Łukasz, Wiszpolska, Marta, Łopieńska-Biernat, Elżbieta, Bossowska, Agnieszka, Majewski, Mariusz Krzysztof, Majewska, Marta
• Format: Article
• Language: English
• Subjects: Administration, Intravesical; Alcohol; Analysis; animal model; Animals; Aqueous solutions; Bioinformatics; Bladder; Capsaicin; Capsaicin receptors; Degeneration; Diterpenes - pharmacology; Dosage and administration; Ethanol; Experiments; Folic acid; Gene expression; Gene Expression Profiling; Genomes; High-throughput screening (Biochemical assaying); Hydrogen sulfide; Laboratory animals; Metabolic pathways; Methods; Myelination; Neuromodulation; Neuroprotection; Pain; Pain perception; Quality control; Resiniferatoxin; RNA-Seq; Sensory receptors; Serotonin; Swine; Synaptic plasticity; Transcriptomics; Urinary Bladder; urinary bladder wall; Urinary tract; Urogenital system; γ-Aminobutyric acid
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12030462

Resiniferatoxin (RTX) is a potent capsaicin analog used as a drug for experimental therapy to treat neurogenic disorders associated with enhanced nociceptive transmission, including lower urinary tract symptoms. The present study, for the first time, investigated the transcriptomic profile of control and RTX-treated porcine urinary bladder walls. We applied multistep bioinformatics and discovered 129 differentially expressed genes (DEGs): 54 upregulated and 75 downregulated. Metabolic pathways analysis revealed five significant Kyoto Encyclopedia of Genes and Genomes (KEGG) items ('folate biosynthesis', 'metabolic pathways', 'sulfur relay system', 'sulfur metabolism' and 'serotonergic synapse') that were altered after RTX intravesical administration. A thorough analysis of the detected DEGs indicated that RTX treatment influenced the signaling pathways regulating nerve growth, myelination, axon specification, and elongation. Many of the revealed DEGs are involved in the nerve degeneration process; however, some of them were implicated in the initiation of neuroprotective mechanisms. Interestingly, RTX intravesical installation was followed by changes in the expression of genes involved in synaptic plasticity and neuromodulation, including 5-HT, H2S, glutamate, and GABA transmission. The obtained results suggest that the toxin may exert a therapeutic, antinociceptive effect not only by acting on TRPV1 receptors.